bioAffinity Technologies, Inc. — Director's Dealing 2024

Jun 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2024-06-12

Reporting Person: Rubin Gary D (Director, 10% Owner)
Reporting Person: Harvey Sandler Revocable Trust (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-12	Common Stock	A	8296	$0.00	Acquired	112813	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1584144	Indirect

Footnotes

F1: Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately.

F2: Represents shares of common stock owned directly by the Harvey Sandler Revocable Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. Rubin, as co-trustee of the Trust.. Mr. Rubin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.